Australia markets closed

Crinetics Pharmaceuticals, Inc. (CRNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
53.14+0.37 (+0.70%)
At close: 04:00PM EDT
54.00 +0.86 (+1.62%)
After hours: 07:11PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,385
4,013
4,737
1,078
0
Operating expenses
Research development
201,104
168,527
130,225
84,255
56,998
Selling general and administrative
78,228
58,094
42,394
24,525
18,026
Total operating expenses
279,332
226,621
172,619
108,780
74,953
Operating income or loss
-277,947
-222,608
-167,882
-107,702
-74,953
Total other income/expenses net
-5,945
-5,357
-353
-96
150
Income before tax
-258,540
-214,529
-163,918
-107,641
-73,812
Income from continuing operations
-258,540
-214,529
-163,918
-107,641
-73,812
Net income
-258,540
-214,529
-163,918
-107,641
-73,812
Net income available to common shareholders
-258,540
-214,529
-163,918
-107,641
-73,812
Basic EPS
-3.64
-3.69
-3.15
-2.80
-2.42
Diluted EPS
-3.64
-3.69
-3.15
-2.80
-2.42
Basic average shares
54,717
58,071
51,982
38,436
30,448
Diluted average shares
54,717
58,071
51,982
38,436
30,448